Sustained release of venlafaxine from venlafaxine-montmorillonite-polyvinylpyrrolidone composites

Applied Clay Science

Volumn 51, Issue 1-2, 2011, Pages 126-130

  Patel, Hasmukh A ^a   Shah, Sunil ^a   Shah, Dinesh O ^a,b   Joshi, P A ^a  

^a DHARMSINH DESAI UNIVERSITY   (India)

^b University of Florida   (United States)

Author keywords

Composites; Montmorillonite; Polyvinylpyrrolidone; Sustained release; Venlafaxine

Indexed keywords

COMPOSITES; MONTMORILLONITE; POLY VINYL PYRROLIDONE; SUSTAINED RELEASE; VENLAFAXINE;

CLAY MINERALS; ION EXCHANGE; SILICATE MINERALS;

DRUG PRODUCTS;

COMPOSITE; DRUG; ION EXCHANGE; MONTMORILLONITE; POLYMER;

EID: 78650728227     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2010.11.013     Document Type: Article

References (24)

1. Bergaya F., Theng B.K.G., Lagaly G. Handbook of Clay Science 2006, Elsevier, The Netherland. First Edition.
2. Bernardi L.S., Oliveira P.R., Murakami F.S., Silva M.A.S., Borgmann S.H.M., Cardoso S.G. Characterization of venlafaxine hydrochloride and compatibility studies with pharmaceutical excipients. J. Therm. Anal. Calorim. 2009, 97:729-733.
3. Carrdinal J.R. Drug release from matrix devices. Recent Advances in Drug Delivery Systems 1984, 229. Plenum Press, New York. J.M. Anderson, S.W. Kim (Eds.).
4. Efentakis M., Politis S. Comparative evaluation of various structures in polymer controlled drug delivery systems and the effect of their morphology and characteristics on drug release. Eur. Polym. J. 2006, 42:1183-1195.
5. Entsuah R., Chitra R. A benefit-risk analysis of once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Psychopharmacol. Bull. 1997, 33:671-676.
6. Fejer I., Kata M., Eros I., Berkesi O., Dekany I. Release of cationic drug from loaded clay minerals. Colloid Polym. Sci. 2001, 279:1177-1182.
7. Haeusler J.C. Change in formulation and its potential clinical and pharmacoeconomic value: example of extended release venlafaxine. Curr. Med. Res. Opin. 2009, 25:1089-1094.
8. Haskins J.T., Moyer J.A., Muth E.A., Sigg E.B. Wy-45, 881 and ciramadol inhibit locus coeruleus neuronal activity. Eur. J. Pharmacol. 1985, 115:139-146.
9. Ho-Wah H., Robinson J., Lee V. Design and fabrication of oral controlled release drug delivery systems. Controlled Drug Delivery 1987, 373. Marcell Dekker Inc., New York. J. Robinson, V. Lee (Eds.).
10. Jablonski E., Lang A.J., Vyazovkin S. Isoconversional kinetics of degradation of polyvinylpyrrolidone used as a matrix for ammonium nitrate stabilization. Thermochim. Acta 2008, 474:78-80.
11. Joshi G.V., Patel H.A., Bajaj H.C., Jasra R.V. Intercalation and control release of vitamin B6 from montmorillonite-vitamin B6 hybrids. Colloid Polym. Sci. 2009, 287:1071-1076.
12. Joshi G.V., Patel H.A., Kevadiya B.D., Bajaj H.C. A study of montmorillonite intercalated with vitamin B1 as drug carrier. Appl. Clay Sci. 2009, 45:248-253.
13. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., Jasra R.V. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int. J. Pharmaceu. 2009, 374:53-57.
14. Klamerus K.J., Maloney K., Rudolph R.L., Sisenwine S.F., Jusko W.J., Chiang S.T. Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite. J. Clin. Pharmacol. 1992, 32:716-724.
15. Lin F.H., Lee Y.H., Jian C.H., Wong J.M., Shieh M.J., Wang C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 2002, 23:1981-1987.
16. Makhija S.N., Vavia P.R. Once daily sustained release tablets of venlafaxine, a novel antidepressant. Eur. J. Pharmaceu. Biopharmaceu. 2002, 54:9-15.
17. Nunes C.D., Vaz P.D., Fernandes A.C., Ferreira P., Romao C.C., Calhorda M.J. Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur. J. Pharm. Biopharm. 2007, 66:357-365.
18. Olver J.S., Burrows G.D., Norman T.R. Third-generation antidepressants: do they offer advantages over the SSRIs?. CNS Drugs 2001, 15:941-954.
19. Patel H.A., Somani R.S., Bajaj H.C., Jasra R.V. Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and wastewater treatment. Bull. Mater. Sci. 2006, 29:133-145.
20. Patel H.A., Somani R.S., Bajaj H.C., Jasra R.V. Preparation and characterization of phosphonium montmorillonite with enhanced thermal stability. Appl. Clay Sci. 2007, 35:194-200.
21. Patel H.A., Somani R.S., Bajaj H.C., Jasra R.V. Synthesis and characterization of organic bentonite using Gujarat and Rajasthan clays. Curr. Sci. 2007, 92:1004-1009.
22. Shah S., Pal A., Kaushik V.K., Devi S. Preparation and characterization of venlafaxine hydrochloride-loaded chitosan nanoparticles and in vitro release of drug. J. Appl. Polym. Sci. 2009, 112:2876-2887.
23. Yang H., Lopina S.T. Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks. J. Biomed. Mater. Res. 2005, 72A:107-114.
24. Zheng J.P., Luan L., Wang H.Y., Xi L.F., Yao K.D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl. Clay Sci. 2007, 36:297-301.